Literature DB >> 9621037

Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells.

R E Sutton1, H T Wu, R Rigg, E Böhnlein, P O Brown.   

Abstract

Lentiviruses are potentially advantageous compared to oncoretroviruses as gene transfer agents because they can infect nondividing cells. We demonstrate here that human immunodeficiency virus type 1 (HIV-1)-based vectors were highly efficient in transducing purified human hematopoietic stem cells. Transduction rates, measured by marker gene expression or by PCR of the integrated provirus, exceeded 50%, and transduction appeared to be independent of mitosis. Derivatives of HIV-1 were constructed to optimize the vector, and a deletion of most of Vif and Vpr was required to ensure the long-term persistence of transduced cells with relatively stable expression of the marker gene product. These results extend the utility of this lentivirus vector system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621037      PMCID: PMC110379     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  The current status of gene therapy using hematopoietic stem cells.

Authors:  D B Kohn
Journal:  Curr Opin Pediatr       Date:  1995-02       Impact factor: 2.856

2.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 3.  The basic science of gene therapy.

Authors:  R C Mulligan
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

4.  Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.

Authors:  U von Schwedler; J Song; C Aiken; D Trono
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

Review 5.  Gene transfer therapy for heritable disease: cell and expression targeting.

Authors:  K Mitani; P R Clemens; A B Moseley; C T Caskey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1993-02-27       Impact factor: 6.237

6.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.

Authors:  C J Li; D J Friedman; C Wang; V Metelev; A B Pardee
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

7.  The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.

Authors:  U von Schwedler; R S Kornbluth; D Trono
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.

Authors:  P F Lewis; M Emerman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

10.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  40 in total

1.  A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.

Authors:  N Srinivasakumar; F G Schuening
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

Authors:  S S Case; M A Price; C T Jordan; X J Yu; L Wang; G Bauer; D L Haas; D Xu; R Stripecke; L Naldini; D B Kohn; G M Crooks
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro.

Authors:  I Hamaguchi; N B Woods; I Panagopoulos; E Andersson; H Mikkola; C Fahlman; R Zufferey; L Carlsson; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.

Authors:  Ulrich Kuhn; Atsushi Terunuma; Wolfgang Pfutzner; Ruth Ann Foster; Jonathan C Vogel
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 5.  Gene-marking studies of hematopoietic cells.

Authors:  C M Bollard; H E Heslop; M K Brenner
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

6.  Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.

Authors:  Yijun Zhang; James H Chapman; Asim Ulcay; Richard E Sutton
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells.

Authors:  H Mikkola; N B Woods; M Sjögren; H Helgadottir; I Hamaguchi; S E Jacobsen; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Identification of synthetic endothelial cell-specific promoters by use of a high-throughput screen.

Authors:  Christine Dai; Robin E McAninch; Richard E Sutton
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Authors:  Alexey V Gordadze; Chisaroka W Onunwor; RongSheng Peng; David Poston; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages.

Authors:  Li-Ying Liou; Christine H Herrmann; Andrew P Rice
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.